OMADA HEALTH INC

OMADA Health insider sale: President Shao Wei‑Li sells 8,866 shares at $25.02, a routine 10(b)(5) move reflecting solid fundamentals and modest portfolio rebalancing.

CEO Sean P. Duffy’s structured OMADA Health trades—buying at $25, selling earlier—show confidence in the stock’s rally, boosting investor confidence.

Insightful analysis of OMADA Health CEO Sean Duffy’s 10(b)(5)(1) buy‑sell trades: why insider activity matters, market impact, and investor takeaways.

Insider buy of 26,655 OMADA Health shares signals board confidence, as clinical trials show 5‑7% weight loss and 0.6‑0.8% HbA1c reduction with safe, FDA‑supported digital care.

Inside OMADA Health’s latest insider moves: chief accountant buys low, sells high and exercises options—what this means for investors and stock volatility.

CEO Sean Duffy’s $22.98 purchase of OMADA Health shares signals insider confidence amid a growing digital‑health boom—an inside look at why this 1.4 B‑dollar stock matters.

Discover how OMADA Health’s insiders use 10(b)(5) trading to signal confidence, boost valuation, and navigate a crowded virtual‑health market.

Explore OMADA Health’s June insider sales, market gains, and growth strategy—why executives are selling and what it means for investors.

CEO Sean Duffy sells 2,800 OMADA Health shares at $19.01, showing disciplined insider trading without affecting the company’s strong growth outlook.

OMADA Health insider sales stay low‑volume and rule‑compliant, adding modest liquidity while keeping stock price stable in a growing value‑based care market.